Treatment of shock with dextrans and gelatins. Effects and side effects.
D000707:Anaphylaxis; D000941:Antigens; D001775:Blood Circulation / Q000187:drug effects; D001777:Blood Coagulation / Q000187:drug effects; D001810:Blood Volume; D003102:Colloids; D003911:Dextrans / Q000009:adverse effects / Q000627:therapeutic use*; D005780:Gelatin / Q000009:adverse effects / Q000627:therapeutic use*; D006636:Histamine Release; D006801:Humans; D007668:Kidney / Q000187:drug effects; D007773:Lactates / Q000627:therapeutic use; D008353:Mannitol / Q000627:therapeutic use; D008407:Mast Cells / Q000187:drug effects; D008970:Molecular Weight; D010952:Plasma Substitutes; D011506:Proteins / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D012769:Shock / Q000188:drug therapy*; D014783:Viscosity
D000941:Antigens; D003102:Colloids; D003911:Dextrans; D007773:Lactates; D010952:Plasma Substitutes; D011506:Proteins; D012701:Serotonin; D008353:Mannitol; D005780:Gelatin